Skip to content
Screener

Cytek Biosciences, Inc. CTKB Book value per share

Book value per share at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$142.01+6.3%
Danaher logo
DanaherDHR
$74.31+2.1%
Revvity logo
RevvityRVTY
$64.76+0.7%
Agilent Technologies logo
Agilent TechnologiesA
$25.17+16.9%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$34.00-7.0%
Bruker logo
BrukerBRKR
$15.76+31.4%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Calculated from Cytek Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496

FAQ

What is Cytek Biosciences, Inc.'s book value per share?
Cytek Biosciences, Inc. (CTKB) reported book value per share of $2.49 in Q2 2026.
How has Cytek Biosciences, Inc.'s book value per share changed year-over-year?
Cytek Biosciences, Inc.'s book value per share decreased by 16.4% year-over-year, from $2.97 to $2.49.
What is the long-term trend for Cytek Biosciences, Inc.'s book value per share?
Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s book value per share has grown at a 40.3% compound annual growth rate (CAGR), from -$0.49 to $2.68.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Cytek Biosciences, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude